Corcept Therapeutics (CORT) Non-Current Debt (2012 - 2016)

Corcept Therapeutics has reported Non-Current Debt for 5 years, with the latest figure at $3.7 million in Q2 2016.

• Quarterly Non-Current Debt fell 80.7% year-over-year to $3.7 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $3.7 million (down 80.7% YoY) and the FY2015 annual result came in at $12.5 million, down 48.79% from the prior year.
• Non-Current Debt eased to $3.7 million in Q2 2016 per CORT's latest filing, from $8.7 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $30.2 million in Q2 2013 and troughed at $3.7 million in Q2 2016.
• A 5-year average of $22.8 million and a median of $26.8 million in 2014 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2013 and 2016: Non-Current Debt advanced 6.41% in 2013, then plunged 80.7% in 2016.
• Over 5 years, Non-Current Debt stood at $29.0 million in 2012, then advanced by 1.01% to $29.3 million in 2013, then dropped by 16.57% to $24.5 million in 2014, then slumped by 48.79% to $12.5 million in 2015, then slumped by 70.11% to $3.7 million in 2016.
• According to Business Quant data, Non-Current Debt over the past three periods registered $3.7 million, $8.7 million, and $12.5 million for Q2 2016, Q1 2016, and Q4 2015 respectively.